{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:03:53Z","timestamp":1753891433880,"version":"3.41.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Coronavirus disease-2019 (COVID-19) has spread rapidly around the world and has become a public health emergency of international concern. The weekly epidemiological report issued by the WHO pointed out that new coronavirus variants have appeared in 131 countries and regions, which demonstrates that the current epidemic situation is still severe. As of now, the severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been widespread worldwide for more than one year and poses a serious threat to the health of vulnerable groups such as those with malignancies, the elderly, and the immunocompromised. Compared with the general population, cancer patients with COVID-19 infection are more likely to have serious clinical adverse events, leading to higher mortality. There is no doubt that during the COVID-19 epidemic, whether it is with regards to how to prevent infection or how to continue anti-tumor treatment, cancer patients are in a difficult situation. Meanwhile, an international patient with malignant Hodgkin\u2019s lymphoma who was cured after being infected with the new coronavirus surprised us, and it inspires more scientists to explore the relationship between infection, immunity, and tumors. Relevantly, through multi-disciplinary discussion, scientists put forward more new perspectives on the treatment of future tumors and the management of SARS-CoV-2 diseases. In this review, the impact of COVID-19 on cancer patients is discussed in detail and the recommendations for the diagnosis, treatment and management of cancer patients will be put forward under the challenge of the COVID-19 epidemic. Furthermore, the safety and effectiveness of the SARS-CoV-2 vaccine will be discussed, and we will also put forward our insights on cancer immunity.<\/jats:p>","DOI":"10.3389\/fmolb.2021.673360","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T17:00:28Z","timestamp":1625158828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Management and Thinking on the Treatment of Cancer Patients During the COVID-19"],"prefix":"10.3389","volume":"8","author":[{"given":"Shuangyue","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2020200642","article-title":"Correlation of chest CT and RT-PCR testing in Coronavirus. Disease 2019 (COVID-19) in China: a report of 1014 cases.","volume":"296","author":"Ai","year":"2020","journal-title":"Radiology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome.","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2020-0213","article-title":"A practical approach to the management of cancer patients during the novel Coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group.","volume":"25","author":"Al-Shamsi","year":"2020","journal-title":"Oncologist"},{"journal-title":"Bacillus Calmette-Gu\u00e9rin Immunotherapy for Bladder Cancer Overview of BCG Immunotherapy.","year":"2021","author":"Babaian","key":"B4"},{"key":"B5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-000785","article-title":"How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.","volume":"4","author":"Banna","year":"2020","journal-title":"ESMO Open"},{"key":"B7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/curroncol13040012","article-title":"Influenza pandemic planningfor cancer patients.","volume":"13","author":"Battershill","year":"2006","journal-title":"Curr. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13813455.2020.1791188","article-title":"Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus.","volume":"9","author":"BourBour","year":"2020","journal-title":"Arch. Physiol. Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.clml.2012.06.007","article-title":"Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections.","volume":"12","author":"Buckner","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"year":"2021","key":"B10"},{"journal-title":"Interim Infection Prevention and Control Recommendations for Healthcare Personnel during the Coronavirus Disease 2019 (COVID-19) Pandemic.","year":"2020","key":"B11"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17116","article-title":"SARS-CoV-2-induced remission of Hodgkin lymphoma.","volume":"192","author":"Challenor","year":"2021","journal-title":"Haematology"},{"key":"B13","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1148\/radiol.2020200230","article-title":"CT imaging features of 2019 novel Coronavirus (2019-nCoV).","volume":"295","author":"Chung","year":"2020","journal-title":"Radiology"},{"key":"B14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with Cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 Outbreak.","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.577696","article-title":"Differentiation of COVID-19 pneumonitis and ICI induced pneumonitis.","volume":"10","author":"Dumoulin","year":"2020","journal-title":"Front. Oncol."},{"journal-title":"FDA Guidance on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic.","year":"2020","key":"B16"},{"key":"B17","doi-asserted-by":"crossref","DOI":"10.1007\/s11912-020-00934-7","article-title":"COVID-19 and cancer: a comprehensive review.","volume":"22","author":"Gosain","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jamaoncol.2020.2482","article-title":"Cancer survivorship-considering mindsets.","volume":"6","author":"Heathcote","year":"2020","journal-title":"JAMA Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8020","DOI":"10.1002\/cam4.3435","article-title":"SARS-CoV-2 infections in cancer outpatients\u2014Most infected patients are asymptomatic carriers without impact on chemotherapy.","volume":"9","author":"Hempel","year":"2020","journal-title":"Cancer Med."},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(20)30773-8","article-title":"What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2.","volume":"21","author":"Hodgson","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"B21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11606-020-05762-w","article-title":"Review of the clinical characteristics of Coronavirus disease 2019 (COVID-19).","volume":"35","author":"Jiang","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2217\/imt-2020-0077","article-title":"Do checkpoint inhibitors compromise the cancer patients\u2019 immunity and increase the vulnerability to COVID-19 infection?","volume":"12","author":"Kattan","year":"2020","journal-title":"Immunotherapy"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003967","article-title":"Are we harming cancer patients by delaying their cancer surgery during the COVID-19 pandemic?","author":"Kiran","year":"2020","journal-title":"Ann. Surg."},{"key":"B25","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/s1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071238","article-title":"The impact of telehealthcare on the quality and safety of care: a systematic overview.","volume":"8","author":"McLean","year":"2013","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.0004-8461.2003.01165.x","article-title":"Hiding in the Bunker: challenges for a radiation oncology department operating in the Severe Acute Respiratory Syndrome outbreak.","volume":"47","author":"Mukherjee","year":"2003","journal-title":"Austr. Radiol."},{"year":"2020","key":"B29","article-title":"Oncology, Prevention and Treatment of Cancer-Related Infections. NCCN clinical guidelines."},{"key":"B30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(20)31182-X","article-title":"Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.","volume":"396","author":"Nepogodiev","year":"2020","journal-title":"Lancet"},{"year":"","key":"B31","article-title":"Real-time big data report on the novel Coronavirus pneumonia outbreak."},{"key":"B32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/107327481702400212","article-title":"Fever in patients with cancer.","volume":"24","author":"Pasikhova","year":"2017","journal-title":"Cancer Control."},{"key":"B33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1592\/phco.30.1.57","article-title":"Drug fever.","volume":"30","author":"Patel","year":"2010","journal-title":"Pharmacotherapy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections-more than just the common cold.","volume":"323","author":"Paules","year":"2020","journal-title":"JAMA"},{"journal-title":"Pfizer And Biontech Announce Vaccine Candidate Against Covid-19 Achieved Success In First Interim Analysis From Phase 3 Study.","year":"2020","key":"B35"},{"key":"B36","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s11523-020-00721-1","article-title":"Impact of the COVID-19 outbreak on the management of patients with cancer.","volume":"15","author":"Raymond","year":"2020","journal-title":"Target Oncol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective.","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1574-6976.2008.00118.x","article-title":"Influence of BCG vaccine strain on the immune response and protection against tuberculosis.","volume":"32","author":"Ritz","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41591-020-0979-0","article-title":"Determinants of COVID-19 disease severity in patients with cancer.","volume":"26","author":"Robilotti","year":"2020","journal-title":"Nat. Med."},{"key":"B40","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy.","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"482","DOI":"10.12968\/bjcn.2019.24.10.482","article-title":"Delivering chemotherapy at home: how much do we know?","volume":"24","author":"Shereen","year":"2019","journal-title":"Br. J. Commun. Nurs."},{"key":"B42","first-page":"125","article-title":"Telemedicine in cancer care.","volume":"38","author":"Sirintrapun","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.chest.2018.08.1048","article-title":"Immune Checkpoint immunotherapy for non-small cell lung cancer: benefits and pulmonary toxicities.","volume":"154","author":"Suresh","year":"2018","journal-title":"Chest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2196\/19691","article-title":"Virtual management of patients with cancer during the COVID-19 pandemic: web-based questionnaire study.","volume":"22","author":"Tashkandi","year":"2020","journal-title":"J. Med. Internet Res."},{"journal-title":"Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings \u2013Recommendations of the HICPAC.","year":"2018","key":"B45"},{"key":"B46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.46234\/ccdcw2020.032","article-title":"Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel Coronavirus diseases (COVID-19) \u2014 China, 2020.","volume":"2","year":"2020","journal-title":"China CDC Weekly"},{"key":"B47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","article-title":"Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.","volume":"21","author":"Tian","year":"2020","journal-title":"Lancet Oncol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/tmi.13383","article-title":"The COVID-19 epidemic.","volume":"25","author":"Velavan","year":"2020","journal-title":"Trop. Med. Int. Health"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17051729","article-title":"Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus Disease (COVID-19) epidemic among the general population in China.","volume":"17","author":"Wang","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B50","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(20)30149-2","article-title":"Risk of COVID-19 for patients with cancer.","volume":"21","author":"Wang","year":"2020","journal-title":"Lancet Oncol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.radonc.2020.03.029","article-title":"Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: experience of the Hubei Cancer hospital in Wuhan, China.","volume":"148","author":"Wei","year":"2020","journal-title":"Radiother. Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/bjh.16620","article-title":"Care of haematology patients in a COVID-19 epidemic.","volume":"189","author":"Willan","year":"2020","journal-title":"Br. J. Haematol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cac2.12077","article-title":"Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors.","volume":"40","author":"Wu","year":"2020","journal-title":"Cancer Commun."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4495-2","article-title":"The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.","volume":"18","author":"Yao","year":"2018","journal-title":"BMC Cancer"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/jamaoncol.2020.0980","article-title":"SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan, China.","volume":"6","author":"Yu","year":"2020","journal-title":"JAMA Oncol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.21037\/tlcr-20-892","article-title":"COVID-19 and early-stage lung cancer both featuring ground-glass opacities: a propensity score-matched study.","volume":"9","author":"Zhang","year":"2020","journal-title":"Transl. Lung Cancer Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/jmv.25889","article-title":"The impact of COPD and smoking history on the severity of COVID-19: a systemic review and meta-analysis.","volume":"92","author":"Zhao","year":"2020","journal-title":"J. Med. Virol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1111\/1759-7714.13424","article-title":"Recommendations of individualized medical treatment and common adverse events management for lung cancer patients during the outbreak of COVID-19 epidemic.","volume":"11","author":"Zhao","year":"2020","journal-title":"Thorac. Cancer"}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.673360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T10:25:45Z","timestamp":1672655145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2021.673360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":59,"alternative-id":["10.3389\/fmolb.2021.673360"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2021.673360","relation":{},"ISSN":["2296-889X"],"issn-type":[{"type":"electronic","value":"2296-889X"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"673360"}}